In ₹ Crore except Per Share Latest Annual	METROPOLIS FY26	LALPATHLAB FY26	VIJAYA FY26	THYROCARE FY26	Peer Average
Valuation — at last close
P/E	60.27×	63.22×	87.10×	◆ 50.19×	66.84× -10%
P/B	◆ 7.59×	12.77×	15.74×	14.02×	14.18× -46%
EV/EBITDA	◆ 28.22×	39.29×	43.88×	30.48×	37.88× -26%
Market Cap	₹11,483 Cr	₹32,040 Cr	₹15,066 Cr	₹8,205 Cr	₹18,437 Cr -38%
Growth
Revenue CAGR 3Y	12.75%	11.06%	◆ 21.03%	16.33%	16.14% -21%
Revenue CAGR 5Y	10.52%	11.81%	◆ 16.66%	10.88%	13.12% -20%
Net Income CAGR 3Y	10.06%	28.35%	26.62%	◆ 36.27%	30.41% -67%
Revenue YoY (latest Q)	16.62%	19.10%	22.83%	◆ 25.07%	22.33% -26%
Net Income YoY (latest Q)	25.72%	27.24%	◆ 37.61%	-68.17%	-1.11% +2424%
Profitability
EBITDA Margin	24.36%	28.32%	◆ 41.38%	31.61%	33.77% -28%
Net Income Margin	11.62%	18.45%	◆ 21.24%	19.64%	19.78% -41%
Return on Common Equity	13.36%	21.57%	19.74%	◆ 28.80%	23.37% -43%
Return on Capital Employed	15.82%	24.78%	19.65%	◆ 33.68%	26.04% -39%
Return on Assets	9.55%	17.39%	12.44%	◆ 22.62%	17.48% -45%
Credit & Quality
Total Debt/Equity	0.01×	◆ 0.00×	0.00×	0.00×	0.00×
Interest Coverage	10.88×	27.22×	7.38×	◆ 72.66×	35.75× -70%
Scale — latest FY
Revenue / Total Income	₹1,646 Cr	₹2,763 Cr	₹814 Cr	₹829 Cr	₹1,469 Cr +12%
Net Income	₹191 Cr	₹510 Cr	₹173 Cr	₹163 Cr	₹282 Cr -32%
Total Assets	₹2,138 Cr	₹3,146 Cr	₹1,507 Cr	₹747 Cr	₹1,800 Cr +19%
EPS	₹9.19	₹30.24	₹16.81	₹10.27	₹19.11 -52%
Book Value per Share	₹72.98	₹149.65	₹93.02	₹36.78	₹93.15 -22%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.